Inhibition of growth and increased expression of insulin-like growth factor-binding protein-3 (IGFBP-3) and-6 in prostate cancer cells stably transfected with antisense IGFBP-4 complementary deoxyribonucleic acid

Citation
Rh. Drivdahl et al., Inhibition of growth and increased expression of insulin-like growth factor-binding protein-3 (IGFBP-3) and-6 in prostate cancer cells stably transfected with antisense IGFBP-4 complementary deoxyribonucleic acid, ENDOCRINOL, 142(5), 2001, pp. 1990-1998
Citations number
59
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
ENDOCRINOLOGY
ISSN journal
00137227 → ACNP
Volume
142
Issue
5
Year of publication
2001
Pages
1990 - 1998
Database
ISI
SICI code
0013-7227(200105)142:5<1990:IOGAIE>2.0.ZU;2-S
Abstract
Insulin-like growth factor-binding proteins (IGFBPs) both stimulate and inh ibit IGF activity, and in the M12 prostate cancer cell line, overexpression of IGFBP-4 was shown to delay tumorigenesis while decreasing the productio n of IGFBP-2. We have performed the reverse experiment, inhibition of IGFBP -4 expression with antisense complementary DNA, in two prostate tumor cell lines, ALVA-31 and M12. Expression of antisense messenger RNA transcripts w as verified by RNase protection assays, and inhibition of mature IGFBP-4 in cell medium was demonstrated by Western blotting. Both transfected lines ( ALVA-31asBP4 and M12asBP4) proliferated more slowly in monolayer culture th an parental controls. Colony formation in soft agar was strongly inhibited in both cases, and the rate of tumor formation and growth in male athymic n ude mice injected with M12asBP4 was markedly reduced relative to that in mi ce receiving M12 control cells. Apoptosis induced by the topoisomerase inhi bitor etoposide was also enhanced in transfected cells. The effects on colo ny formation in soft agar and tumor formation in mice were maintained for t he duration of the experiments, in contrast to the delayed growth observed in the previous study of IGFBP-4 overexpression. A significant difference w as found in the patterns of IGFBP expression; production of both messenger RNA and protein for IGFBP-3 and IGFBP-6 was greatly increased in the M12asB P4 and ALVA31asBP4 cell lines. Up-regulation of these binding proteins has been observed in association with actions of 1,25-dihydroxyvitamin D-3 in p rostate cancer cells, and the data suggest a role for IGFBP-3 and IGFBP-6 i n the suppression of prostate tumor cell growth.